Investor Type Firm
Type of Fund Corporate VC
Industries Businesses Solutions
Investing United States
Investment Range $7,000,000  -  $50,602,514

Investors who are part of this firm

About The Fund

MedImmune Ventures was the corporate venture arm of MedImmune. The firm used to invest in private companies which develops small and large molecules, vaccines, pharmaceutical technologies and platforms. The firm also used to invest in the medical device, diagnostic, imaging and healthcare information technology companies which pertain to the discovery, development and commercialization of pharmaceutical products. It was established in 2002 and was based in Gaithersburg, Maryland.

MedImmune Ventures's investments on record

VentiRx Pharmaceuticals $50,602,514.00 Series B
Ambit Biosciences $50,000,000.00 Venture Round
G1 Therapeutics $50,000,000.00
G1 Therapeutics, Inc. $47,000,000.00 Series C
Applied Genetics Technologies Corporation $37,500,000.00 Series B
G1 Therapeutics, Inc. $33,000,000.00 Series B
Catabasis Pharmaceuticals $32,400,000.00 Series B
G1 Therapeutics, Inc. $12,500,000.00 Series A
Coferon $12,000,000.00 Series B
angels partners Overview

Contact over 100,000 investors!

Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.

With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.

View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.

e We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.

 

Register to become visible to a large community of investors on our platform.

Sign up Log in
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New Startups Started their fundraising over the last 7 days